{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:31:20Z","timestamp":1791469880120,"version":"4.3.4"},"reference-count":20,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"1","license":[{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Rheumatology"],"abstract":"<jats:p>Objectives: This study aimed to translate the Scleroderma Skin Patient-Reported Outcome (SSPRO) questionnaire to the Turkish (SSPRO-T) language and to assess its validity and reliability.\r\nPatients and methods: Fifty-four systemic sclerosis (SSc) patients (51 females, 3 males; mean age: 49.8\u00b110.4 years; range, 22 to 65 years) participated in the reliability and validity analysis between October 2022 and December 2022. The translation and cross-cultural adaptation of the SSPRO-T was applied in accordance with the procedure described by the Beaton guidelines. The SSPRO-T, the Scleroderma Health Assessment Questionnaire (SHAQ), the Health Assessment Questionnaire Disability Index (HAQ-DI), Skindex-29, and patient global skin severity were conducted in all participants for construct validity. The SSPRO-T was retested to assess its reliability after seven days.\r\nResults: The SSPRO-T had a four-factor structure. The total SSPRO-T score and its subgroups correlated positively with SHAQ, HAQ-DI, Skindex-29, and patient global skin severity. The internal consistency and reliability were excellent in overall SSPRO-T and in the subgroups: physical effect, emotional effect, physical limitation, and social effect (Cronbach\u2019s \u03b1=0.94, 0.80, 0.95, 0.93, and 0.84, respectively). The SSPRO-T had excellent test-retest reliability (r=0.91, p<\/jats:p>","DOI":"10.46497\/archrheumatol.2023.10183","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T06:26:51Z","timestamp":1717050411000},"page":"052-059","source":"Crossref","is-referenced-by-count":1,"title":["Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis"],"prefix":"10.5152","volume":"39","author":[{"family":"Fulden Sari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Zilan Bazancir Apaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hakan Apaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mehmet Kayaalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Abdulsamet Erden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Serdar Can G\u00fcven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Berkan Arma\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ahmet Omma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Orhan Kucuksahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"\u015e\u00fckran Erten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3111","published-online":{"date-parts":[[2024,3,31]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol 2015;37:489-500. doi: 10.1007\/ s00281-015-0505-5.","DOI":"10.1007\/s00281-015-0505-5"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M; Canadian Scleroderma Research Group. Health-related quality of life in systemic sclerosis: A systematic review. Arthritis Rheum 2009;61:1112-20. doi: 10.1002\/art.24676.","DOI":"10.1002\/art.24676"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Li L, Cui Y, Chen S, Zhao Q, Fu T, Ji J, et al. The impact of systemic sclerosis on health-related quality of life assessed by SF-36: A systematic review and meta-analysis. Int J Rheum Dis 2018;21:1884-93. doi: 10.1111\/1756-185X.13438.","DOI":"10.1111\/1756-185X.13438"},{"key":"ref-4","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5."},{"key":"ref-5","unstructured":"Malcarne VL, Hansdottir I, McKinney A, Upchurch R, Greenbergs HL, Henstorf GH, et al. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 2007;34:359-67."},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH. Appearance self-esteem in systemic sclerosis--subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology (Oxford) 2007;46:872-6. doi: 10.1093\/rheumatology\/kem008.","DOI":"10.1093\/rheumatology\/kem008"},{"key":"ref-7","unstructured":"Baubet T, Brunet M, Garcia De La Pe\u00f1a-Lefebvre P, Ta\u00efeb O, Moro MR, Guillevin L, et al. Psychiatric manifestations of systemic sclerosis. Ann Med Interne (Paris) 2002;153:237-41."},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Johnson SR, Hawker GA, Davis AM. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: An evaluation of their measurement properties. Arthritis Rheum 2005;53:256-62. doi: 10.1002\/art.21084.","DOI":"10.1002\/art.21084"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Hinchcliff ME, Beaumont JL, Carns MA, Podlusky S, Thavarajah K, Varga J, et al. Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis. J Rheumatol 2015;42:64-72. doi: 10.3899\/jrheum.140143.","DOI":"10.3899\/jrheum.140143"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Mouthon L, Rannou F, B\u00e9rezn\u00e9 A, Pagnoux C, Ar\u00e8ne JP, Fo\u00efs E, et al. Development and validation of a scale for mouth handicap in systemic sclerosis: The Mouth Handicap in Systemic Sclerosis scale. Ann Rheum Dis 2007;66:1651-5. doi: 10.1136\/ ard.2007.070532.","DOI":"10.1136\/ard.2007.070532"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Kallen MA, Mayes MD, Kriseman YL, de Achaval SB, Cox VL, Suarez-Almazor ME. The symptom burden index: Development and initial findings from use with patients with systemic sclerosis. J Rheumatol 2010;37:1692-8. doi: 10.3899\/jrheum.090504.","DOI":"10.3899\/jrheum.090504"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Temiz Karadag D, Karakas F, Tekeoglu S, Yazici A, Isik OO, Cefle A. Validation of Turkish version of the scleroderma Health Assessment Questionnaire. Clin Rheumatol 2019;38:1917-23. doi: 10.1007\/ s10067-019-04494-5.","DOI":"10.1007\/s10067-019-04494-5"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Man A, Correa JK, Ziemek J, Simms RW, Felson DT, Lafyatis R. Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis. Ann Rheum Dis 2017;76:1374-80. doi: 10.1136\/ annrheumdis-2016-210534.","DOI":"10.1136\/annrheumdis-2016-210534"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186-91. doi: 10.1097\/00007632- 200012150-00014.","DOI":"10.1097\/00007632-200012150-00014"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: An American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747- 55. doi: 10.1136\/annrheumdis-2013-204424.","DOI":"10.1136\/annrheumdis-2013-eular.238"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"K\u00fc\u00e7\u00fckdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 2004;51:14-9. doi: 10.1002\/art.20091.","DOI":"10.1002\/art.20091"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Aksu AE, Urer MS, Sabuncu I, Saracoglu ZN, Chren MM. Turkish version of Skindex-29. Int J Dermatol 2007;46:350-5. doi: 10.1111\/j.1365- 4632.2007.03008.x.","DOI":"10.1111\/j.1365-4632.2007.03008.x"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Pope J. Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patientrated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS). Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S98-111. doi: 10.1002\/acr.20598.","DOI":"10.1002\/acr.20598"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. J Invest Dermatol 1996;107:707-13. doi: 10.1111\/1523-1747.ep12365600.","DOI":"10.1111\/1523-1747.ep12365600"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for testretest reliability of health status instruments. J Clin Epidemiol 2003;56:730-5. doi: 10.1016\/s0895- 4356(03)00084-2.","DOI":"10.1016\/S0895-4356(03)00084-2"}],"container-title":["Archives of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1390\/2472","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1390\/2473","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1390\/2472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:02:13Z","timestamp":1761210133000},"score":1,"resource":{"primary":{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/view\/1390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,31]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,31]]}},"URL":"https:\/\/doi.org\/10.46497\/archrheumatol.2023.10183","relation":{},"ISSN":["2618-6500"],"issn-type":[{"value":"2618-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,31]]}}}